BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 24875166)

  • 1. Langerhans cell histiocytosis: differences and similarities in long-term outcome of paediatric and adult patients at a single institutional centre.
    Maia RC; de Rezende LM; Robaina M; Apa A; Klumb CE
    Hematology; 2015 Mar; 20(2):83-92. PubMed ID: 24875166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Langerhans cell histiocytosis of spine: a comparative study of clinical, imaging features, and diagnosis in children, adolescents, and adults.
    Huang WD; Yang XH; Wu ZP; Huang Q; Xiao JR; Yang MS; Zhou ZH; Yan WJ; Song DW; Liu TL; Jia NY
    Spine J; 2013 Sep; 13(9):1108-17. PubMed ID: 23602327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management and Outcome of Patients With Langerhans Cell Histiocytosis and Single-Bone CNS-Risk Lesions: A Multi-Institutional Retrospective Study.
    Chellapandian D; Shaikh F; van den Bos C; Somers GR; Astigarraga I; Jubran R; Degar B; Carret AS; Mandel K; Belletrutti M; Dix D; Visser J; Abuhadra N; Chang T; Rollins B; Whitlock J; Weitzman S; Abla O
    Pediatr Blood Cancer; 2015 Dec; 62(12):2162-6. PubMed ID: 26179251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late outcomes in children with Langerhans cell histiocytosis.
    Chow TW; Leung WK; Cheng FWT; Kumta SM; Chu WCW; Lee V; Shing MMK; Li CK
    Arch Dis Child; 2017 Sep; 102(9):830-835. PubMed ID: 28442470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reactivation and risk of sequelae in Langerhans cell histiocytosis.
    Pollono D; Rey G; Latella A; Rosso D; Chantada G; Braier J
    Pediatr Blood Cancer; 2007 Jun; 48(7):696-9. PubMed ID: 17252574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Langerhans cell histiocytosis: retrospective analysis of 217 cases in a single center.
    Yağci B; Varan A; Cağlar M; Söylemezoğlu F; Sungur A; Orhan D; Yalçin B; Akyüz C; Kutluk T; Büyükpamukçu M
    Pediatr Hematol Oncol; 2008 Jun; 25(5):399-408. PubMed ID: 18569842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reactivations in multisystem Langerhans cell histiocytosis: data of the international LCH registry.
    Minkov M; Steiner M; Pötschger U; Aricò M; Braier J; Donadieu J; Grois N; Henter JI; Janka G; McClain K; Weitzman S; Windebank K; Ladisch S; Gadner H;
    J Pediatr; 2008 Nov; 153(5):700-5, 705.e1-2. PubMed ID: 18589441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Langerhans Cell Histiocytosis (LCH) in Egyptian Children: Does Reactivation Affect the Outcome?
    Sedky MS; Rahman HA; Moussa E; Taha H; Raafat T; Hassanein O
    Indian J Pediatr; 2016 Mar; 83(3):214-9. PubMed ID: 26133729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of vindesine and prednisone and cyclophosphamide, etoposide, vindesine, and prednisone as first-line treatment for adult Langerhans cell histiocytosis: A single-center retrospective study.
    Duan MH; Han X; Li J; Zhang W; Zhu TN; Han B; Zhuang JL; Wang SJ; Cao XX; Cai HC; Chen M; Yang C; Zhou DB
    Leuk Res; 2016 Mar; 42():43-6. PubMed ID: 26859782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Head and neck manifestation and prognosis of Langerhans' cell histiocytosis in children.
    Nicollas R; Rome A; Belaïch H; Roman S; Volk M; Gentet JC; Michel G; Triglia JM
    Int J Pediatr Otorhinolaryngol; 2010 Jun; 74(6):669-73. PubMed ID: 20363036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Langerhans cell histiocytosis: retrospective evaluation of 123 patients at a single institution.
    Braier J; Chantada G; Rosso D; Bernaldez P; Amaral D; Latella A; Balancini B; Masautis A; Goldberg J
    Pediatr Hematol Oncol; 1999; 16(5):377-85. PubMed ID: 10505313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disease course and late sequelae of Langerhans' cell histiocytosis: 25-year experience at the University of California, San Francisco.
    Willis B; Ablin A; Weinberg V; Zoger S; Wara WM; Matthay KK
    J Clin Oncol; 1996 Jul; 14(7):2073-82. PubMed ID: 8683239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Langerhans' cell histiocytosis (histiocytosis X) of bone. A clinicopathologic analysis of 263 pediatric and adult cases.
    Kilpatrick SE; Wenger DE; Gilchrist GS; Shives TC; Wollan PC; Unni KK
    Cancer; 1995 Dec; 76(12):2471-84. PubMed ID: 8625073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis of clinical, iconographical and pathological characteristics, prognosis and treatment methods for 35 cases of Langerhans cell histiocytosis].
    Yang H; Han XP; Li BJ; Sun L; Zhu HY; Li F; Wang QS; Huang WR; Bo J; Zhao Y; Li HH; Wang SH; Yu L; Jing Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Aug; 22(4):1109-14. PubMed ID: 25130838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nationwide Study of Factors Impacting Survival Outcome and Consequences in Children with Reactivation/Refractory Langerhans Cell Histiocytosis.
    Monsereenusorn C; Suwannaying K; Buaboonnam J; Sathitsamitphong L; Techavichit P; Pakakasama S; Chainansamit SO; Anurathapan U; Komvilaisak P; Traivaree C; Sanpakit K; Charoenkwan P; Seksarn P
    Asian Pac J Cancer Prev; 2024 May; 25(5):1831-1839. PubMed ID: 38809656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Craniospinal Langerhans cell histiocytosis in children: 30 years' experience at a single institution.
    Davidson L; McComb JG; Bowen I; Krieger MD
    J Neurosurg Pediatr; 2008 Mar; 1(3):187-95. PubMed ID: 18352762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Langerhans cell histiocytosis in adult patients--a disease with many faces. Experience of a centre and an overview of the disease symptoms].
    Adam Z; Pour L; Krejcí M; Neubauer J; Vanícek J; Vasků V; Hájek R
    Vnitr Lek; 2008 Nov; 54(11):1063-80. PubMed ID: 19069680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Langerhans' cell histiocytosis of the temporal bone in children.
    Saliba I; Sidani K; El Fata F; Arcand P; Quintal MC; Abela A
    Int J Pediatr Otorhinolaryngol; 2008 Jun; 72(6):775-86. PubMed ID: 18355926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of outcome in children with Langerhans cell histiocytosis.
    Jubran RF; Marachelian A; Dorey F; Malogolowkin M
    Pediatr Blood Cancer; 2005 Jul; 45(1):37-42. PubMed ID: 15768381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Langerhans Cell Histiocytosis in the Pediatric Population: Treatment of Isolated Craniofacial Lesions.
    Gargano F; Welch JJ; Klinge PM; Sullivan SR; Taylor HO
    J Craniofac Surg; 2019 Jun; 30(4):1191-1193. PubMed ID: 31166264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.